Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7205
Source ID: NCT00950677
Associated Drug: Byetta (Exenatide)
Title: The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
Acronym: T2DM
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: Byetta (exenatide)|DRUG: Symlin (pramlintide)
Outcome Measures: Primary: Glucose, concentration and AUC calculations, 4 hours | Secondary: glucagon, concentration and AUC calculations, 4 hrours|gastric emptying, concentration and AUC calculations, 4 hours|pramlintide concentrations, concentration and AUC calculations, 4 hours|exenatide concentrations, concentration and AUC calculations, 4 hours
Sponsor/Collaborators: Sponsor: Baylor College of Medicine | Collaborators: National Institutes of Health (NIH)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Gender: ALL
Age: CHILD, ADULT
Phases: PHASE4
Enrollment: 16
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Start Date: 2009-07
Completion Date: 2011-05
Results First Posted:
Last Update Posted: 2017-04-24
Locations: Baylor College of Medicine, Houston, Texas, 77030, United States
URL: https://clinicaltrials.gov/show/NCT00950677